Glucose-induced dissociation of glucokinase from its regulatory protein in the nucleus of hepatocytes prior to nuclear export  by Kaminski, Martin Tobias et al.
Biochimica et Biophysica Acta 1843 (2014) 554–564
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrGlucose-induced dissociation of glucokinase from its regulatory protein
in the nucleus of hepatocytes prior to nuclear exportMartin Tobias Kaminski a, Julia Schultz b, Rica Waterstradt b, Markus Tiedge b,
Sigurd Lenzen a, Simone Baltrusch b,⁎
a Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany
b Institute of Medical Biochemistry and Molecular Biology, University of Rostock, 18057 Rostock, GermanyAbbreviations: DMEM, Dulbecco's modiﬁed Eagle's m
ﬂuorescent protein; ECFP, enhanced cyan ﬂuorescent pr
nance energy transfer; FRAP, ﬂuorescence recovery after
nase regulatory protein; N/C-ratio, nuclear to cytoplasmic
⁎ Corresponding author at: Institute of Medical Bioche
University of Rostock, D-18057 Rostock, Germany. Tel.:
381 494 5752.
E-mail address: simone.baltrusch@med.uni-rostock.de
0167-4889/$ – see front matter © 2013 Elsevier B.V. All r
http://dx.doi.org/10.1016/j.bbamcr.2013.12.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 August 2013
Received in revised form 18 November 2013
Accepted 4 December 2013
Available online 11 December 2013
Keywords:
Glucokinase
Glucokinase regulatory protein
Hepatocyte
Pancreatic beta cell
Fluorescence microscopy
FLII12Pglu-700μ-δ6The glucose phosphorylating enzyme glucokinase regulates glucosemetabolism in the liver. Glucokinase activity
is modulated by a liver-speciﬁc competitive inhibitor, the glucokinase regulatory protein (GRP), whichmediates
sequestration of glucokinase to the nucleus at low glucose concentrations. However, the mechanism of glucoki-
nase nuclear export is not fully understood. In this study we investigated the dynamics of glucose-dependent
interaction and translocation of glucokinase and GRP in primary hepatocytes using ﬂuorescence resonance ener-
gy transfer, selective photoconversion and ﬂuorescence recovery after photobleaching. The formation of the
glucokinase:GRP complex in the nucleus of primary hepatocytes at 5 mmol/l glucose was signiﬁcantly reduced
after a 2 h incubation at 20 mmol/l glucose. The GRPwas predominantly localized in the nucleus, but amobile fraction
moved between the nucleus and the cytoplasm. The glucose concentration only marginally affected GRP shuttling. In
contrast, the nuclear export rate of glucokinase was signiﬁcantly higher at 20 than at 5 mmol/l glucose. Thus, glucose
was proven to be the driving-force for nuclear export of glucokinase in hepatocytes. Using the FLII12Pglu-700μ-δ6 glu-
cose nanosensor it could be shown that in hepatocytes the kinetics of nuclear glucose inﬂux,metabolismor efﬂuxwere
signiﬁcantly faster compared to insulin-secreting cells. The rapid equilibration kinetics of glucose ﬂux into the nucleus
facilitates dissociation of the glucokinase:GRP complex and also nuclear glucose metabolism by free glucokinase en-
zyme. In conclusion, we could show that a rise of glucose in the nucleus of hepatocytes releases active glucokinase
from the glucokinase:GRP complex and promotes the subsequent nuclear export of glucokinase.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Glucokinase regulates glycolytic ﬂux at physiological millimolar
glucose concentrations in the liver and pancreatic beta cells [1–4]. On
the posttranslational level glucokinase activity is modulated by
conformational changes of the enzyme and interaction with regulatory
proteins [1–4]. Hepatocytes speciﬁcally express the glucokinase regulatory
protein (GRP), which plays an important role as a competitive inhibitor of
glucokinase [5–9].
The glucokinase:GRP interaction depends upon the conformation
of the glucokinase protein, which in turn is crucially determined by
the glucose concentration at the substrate binding site. The GRP binds
glucokinase in the absence of glucose, when the enzyme resides in theedium; EYFP, enhanced yellow
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ights reserved.super-opened conformation with low intrinsic activity [1,5,8,10–15].
Glucose causes a concentration-dependent multiple step transition of
glucokinase to a closed conformation, in which the enzyme is active
and not accessible for interaction with the GRP [10,14,16]. Several
amino acids have been suggested to be crucial for interaction with
GRP [11,15,17], but still required conﬁrmation by co-crystallization of
the glucokinase:GRP complex. Most of the postulated amino acids are
located in three regions of the glucokinase protein. Recently, the crystal
structure of the Xenopus laevis glucokinase:GRP complex has been
generated successfully and revealed two binding domains [15]. One of
these comprises Leu58, which had been postulated from a systematic
randompeptide phage display library screening tomediate GRP binding
[11]. Naturally occurring activating and inactivating glucokinasemutations
also displayed a reduced susceptibility to competitive inhibition by the
GRP [13,18]. The formation of the glucokinase:GRP complex is stimulat-
ed by fructose-6-phosphate and suppressed by fructose-1-phosphate
[1,6,8,19–21]. These fructose phosphates interactwith the samebinding
site in the GRP [21,22]. However, species differences exist in the regula-
tory properties of the GRP [15,23–25].
Binding to theGRP leads to translocation of glucokinase to the nucle-
us in hepatocytes. In pancreatic beta cells, which do not express GRP,
Fig. 1.Direct interaction between glucokinase andGRP and localization of both proteins in
rat hepatocytes. Primary rat hepatocytes grown on glass coverslipswere incubated for 2 h
with 5 mmol/l glucose (white bars) or 20 mmol/l glucose (black bars). Finally, the cells
were ﬁxed and immunostained for glucokinase and GRP. The appropriate secondary
antibody was labeled with Cy3 for glucokinase and Cy5 for GRP. FRET was measured in
the nucleus as an increase in Cy3 ﬂuorescence after Cy5 photobleaching. Exemplarily
shown are merged images before (A) and after (B) photobleaching. Scale bar 2 μm. (C)
Data are expressed as means ± SEM from three individual hepatocyte preparations
with 30 cells in total. ***p b 0.001 (Student's t test). (D) Representative images for
glucokinase and GRP localization at 5 mmol/l glucose and 20 mmol/l glucose are shown.
Scale bar 2 μm. (E) The nuclear/cytoplasmic ratio was calculated for glucokinase and GRP.
Data are expressed as means ± SEM from three individual hepatocyte preparations with
12 cells in total. **p b 0.01; ***p b 0.001 (ANOVA/Bonferroni's test); #p b 0.05;
###p b 0.001 compared to 5 mmol/l glucose (Student's t test).
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ments [1,26]. Thus, nuclear compartmentation of glucokinase is a
regulatory mechanism exclusive to the liver [1,26]. In response to an
increase in the glucose concentration, glucokinase shuttles from the
nucleus to the cytoplasm [5,11,27–30]. Likewise, small molecule
glucokinase activators evoked an increase in cytoplasmic glucokinase
in hepatocytes [12,30,31]. The mechanism of this glucokinase nuclear
export, however, is not precisely understood with respect to the
dynamics of glucokinase:GRP complex dissociation and glucokinase
shuttling [1,8,19,26,28,29,32–36].
The molecular weight of both glucokinase and GRP is clearly above
the reported barrier limit of the nuclear pore complexes. Thus, both
proteins likely require nuclear import and export mechanisms [37].
In the present study we characterized different translocation character-
istics of glucokinase and theGRP in primary hepatocytes using real-time
ﬂuorescence based techniques. The nuclear targeted glucose sensor
FLII12Pglu-700μ-δ6 (FLIPglu) [38,39] revealed rapid nuclear equilibra-
tion kinetics of glucose in hepatocytes. This rapid glucose equilibration
appears to be the driving force for the glucokinase nuclear export,
whereas the GRP serves as a nuclear retaining factor for glucokinase.
2. Materials and methods
2.1. Cell culture
MIN6 and COS cells were grown in DMEM supplemented with
25 mmol/l glucose, 10% (vol/vol) FCS, penicillin, and streptomycin in a
humidiﬁed atmosphere at 37 °C and 5% CO2. RINm5F, RINm5F-rGLUT2
[40] and INS1E cells were grown in RPMI 1640 supplemented with
10 mM glucose, 10% (vol/vol) FCS, penicillin, and streptomycin and for
INS1E cells additionally with 50 μM/l 2-mercaptoethanol in a humidi-
ﬁed atmosphere at 37 °C and 5% CO2. Cells were transfected with the
vector DNA using jetPEI (Qbiogene, Montreal, Canada). Isolation and
culture of primary mouse and rat hepatocytes were performed as
described [11,24]. Hepatocytes were either transfected as described
[11,24] or transduced with adenovirus (FLIPglu or FLIPglu-NUC) at a
MOI of 10.
2.2. Generation of plasmids and adenoviruses
FLII12Pglu-700μ-δ6 (FLIPglu) cDNA (Addgene plasmid 17866) was
subcloned into the pcDNA 3.1 vector [39]. Recombinant FLIPglu adeno-
viruses were generated as described previously [38]. A nuclear targeted
version of FLIPglu was created by subcloning the coding cDNA as a SalI-
NotI fragment into the pCMV/myc/NUC vector (Invitrogen, Carlsbad,
CA, USA). Recombinant nuclear targeted FLIPglu adenoviruses were
generated by subcloning the coding cDNA from the pCMV/myc/NUC
as a SalI-XbaI fragment into the pShuttle-CMV vector. Generation of
enhanced cyan ﬂuorescent protein (ECFP)-GK, enhanced yellow ﬂuo-
rescent protein (EYFP)-GK and EYFP-GRP was described previously
[11]. The EYFP in both vectors was replaced by Dendra2 using AgeI
and BsrGI restriction sites. pTagRFP-GRP was generated by subcloning
the coding cDNA of GRP as a BglII-EcoRI fragment into the pTagRFP-N
vector.
2.3. Glucokinase enzyme activity and western blot analyses
MIN6 cells and hepatocytes were cultured as indicated. The nuclear
fraction was isolated by a stepwise fractionation. Brieﬂy, cells were
lysed in 0.5 ml buffer containing 20 mmol/l HEPES (pH 7.9), 10 mmol/l
KCl, 0.2% NP40, 10% glycerol, 1 mmol/l EDTA, 1 mmol/l DTT, 1 μg/ml
pepstatin, 1 mmol/l PMSF, and protease inhibitors for 10 min on ice.
The cytoplasmic fractionwas collected as supernatant after centrifugation
at 13,000 rpm for 30 s. The pellet was re-suspended in 100 μl buffer con-
taining 20 mmol/l HEPES, 10 mmol/l KCl, 350 mmol/l NaCl, 20% glycerol,
1 mmol/l EDTA, 1 mmol/l DTT, 1 μg/ml pepstatin, 1 mM PMSF, 1 mmol/lvanadate and protease inhibitors for 20 min on ice. The nuclear fraction
was collected as supernatant after centrifugation at 13,000 rpm for 30 s.
The protein concentration was quantiﬁed by the Bradford protein assay.
Glucokinase enzyme activity was measured by an enzyme-coupled
photometric assay as described [11]. A total of 40 μg proteinwas fraction-
ated by reducing 10% SDS-PAGE and electroblotted to polyvinylidine
diﬂuoridemembranes.Western blottingwas performed as described [38]
with antibodies against glucokinase (sc-7908, diluted 1:500, or sc-1980,
diluted 1:500 Santa Cruz Biotechnology, Santa Cruz, CA, USA).
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Fig. 3. Effects of glucose on the ﬂuorescence recovery of EYFP-glucokinase and EYFP-GRP
after photobleaching in rat hepatocytes. Primary rat hepatocytes were transfected with
EYFP, EYFP-glucokinase or EYFP-GRP and incubated for 2 h with 5 mmol/l glucose
(white bars) or 20 mmol/l glucose (black bars). (A) Photobleaching was performed in a
circular region in the nucleus and ﬁnally, the percentage of ﬂuorescence recovery was
determined. Data are expressed asmeans ± SEM from three individual hepatocyte prep-
arations with three cells each. ⁎p b 0.05 (ANOVA/Bonferroni's test). (B, C) Hepatocytes
with two nuclei were selected. Photobleaching was performed in a rectangular region
(dotted line) including half of the cytoplasm and one nucleus of the hepatocyte. Shown
are representative images of a hepatocyte transfected with EYFP-GK and incubated at
20 mmol/l glucose before (Pre), during photobleaching (Bleaching) and after 5 min
(Post). Scale bar 10 μm. Finally the decrease of the EYFP ﬂuorescence in the second
nucleus (white circle) was calculated. (C) Data are expressed as means ± SEM from
three individual hepatocyte preparations with three cells each. ⁎p b 0.05 (Student's t
test).
Fig. 4. Nuclear to cytoplasmic translocation of green and photoconverted red Dendra2-
glucokinase and Dendra2-GRP in rat hepatocytes. Primary rat hepatocyteswere transfected
with Dendra2-GRP or Dendra2-glucokinase and incubated at 20 mmol/l glucose. Hepato-
cytes with two nuclei were selected and green Dendra2 was exclusively photoconverted
in one nucleus and the decrease of the red Dendra2 and increase of green Dendra2 was
monitored over 8 h in both nuclei. (A, B) In the example shown Dendra2-GRP was
photoconverted in the right nucleus (marked by an R). (C) Finally, the change in ﬂuores-
cence recovery was quantiﬁed after 2 h in a photoconverted nucleus in hepatocytes
transfected with Dendra2-GRP (white bars) or Dendra2-glucokinase (black bars). Data
are expressed as means ± SEM from three individual hepatocyte preparations with two
cells each. ⁎p b 0.05 (ANOVA/Bonferroni's test).
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Primary rat hepatocytes were seeded on glass coverslips and incu-
bated for 2 h as indicated. Thereafter, cells were ﬁxed overnight withFig. 2. Time course of nuclear export of glucokinase frommouse and rat hepatocytes. Primary ra
and incubated for 2 h at 5 mmol/l glucose and, thereafter, at 5 mmol/l glucose, 20 mmol/l gluc
glucokinase nuclear/cytoplasmic ratio was calculated before, and 30 and 120 min after swi
shown (C). Scale bar 10 μm. Data are expressed as means ± SEM from three individual hep
Bonferroni's test).4% paraformaldehyde in PBS at 4 °C and immunostained as described
[41] with glucokinase antibody (sc-7908) diluted 1:100 in PBS and
GRP antibody (sc-6340) diluted 1:100 in PBS (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). The appropriate secondary antibodies, Cy3 or Cy5,t (A) andmouse (B, C) hepatocytes were transfectedwith ECFP-glucokinase and EYFP-GRP
ose, 5 mmol/l glucose + 0.2 mmol/l fructose, or 5 mmol/l glucose + 30 μmol/l CpdA. The
tching the medium in the same cells. Representative images of mouse hepatocytes are
atocyte preparations with four cells each. *p b 0.05; **p b 0.01; ***p b 0.001 (ANOVA/
Fig. 5. Shuttling of glucokinase and GRP in rat hepatocytes. Primary rat hepatocytes were transfected with Dendra2, Dendra2-glucokinase or Dendra2-GRP and incubated for 2 h with
5 mmol/l glucose (white bars) or 20 mmol/l glucose (black bars). (A) Shown are representative ﬂuorescence intensity traces of photoconverted red Dendra2-glucokinase in the nucleus
at 5 and 20 mmol/l glucose. The photobleaching period is indicated by a gray background. (B) Finally, the decrease of the red Dendra2 was determined over 15 s. Data are expressed as
means ± SEM from three individual hepatocyte preparationswith three to four cells each. ⁎p b 0.05 (ANOVA/Bonferroni's test). (C) Scheme of glucokinase andGRP shuttling between the
nucleus and cytoplasm at low and high glucose.
558 M.T. Kaminski et al. / Biochimica et Biophysica Acta 1843 (2014) 554–564were diluted 1:200 in PBS (Jackson Immuno Research, West Grove, PA,
USA). Finally, coverslips were washed three times with PBS and ﬁxed
onto slides.
2.5. Fluorescence microscopy
Fluorescence recovery after photobleaching (FRAP) and ﬂuores-
cence distribution after photoconversion measurements were per-
formed using an Olympus Fluoview1000 confocal inverted microscope(Olympus, Hamburg, Germany) with a multi-line argon laser (488 nm,
515 nm) to excite green Dendra2 and EYFP, respectively and a krypton–
argon laser (561 nm) to excite red Dendra2. Each scanning experiment
was carried out over 30 s with a sampling speed of 2 μs/pixel in a
128 × 128 image format. Photobleaching and photoconversion were
conducted simultaneously for one sampling interval with a second
laser scanner and a 405 nm laser diode (25 mW). Image intensities
were quantiﬁed with Olympus FV10-ASW 2.0 software. For lifetime ﬂuo-
rescence resonance energy transfer (FRET) imaging, the system was
Fig. 6. Glucokinase activity and immunoreactivity in rat hepatocytes and MIN6 cells
expressing EYFP-GRP. MIN6 cells were transiently transfected with EYFP-GRP or with
the ﬂuorescence protein EYFP alone as control. Primary rat hepatocytes and MIN6 cells
were cultured at 10 mmol/l glucose and the nuclear fraction was separated by fraction-
ation. Glucokinase activity (A) was analyzed in the residual (white bars) and nuclear
(black bars) fractions. Data are expressed as means ± SEM from three individual experi-
ments. ⁎⁎⁎p b 0.001 (ANOVA/Bonferroni's test). Glucokinase immunoreactivity (B) was
determined in residual (R) and nuclear (N) fractions. A total of 40 μg cellular protein
was loaded. Representative blots of three individual experiments are shown. Localization
of EYFP (C) and EYFP-GRP (D) in MIN6 cells was visualized by ﬂuorescence microscopy.
Representative images of three individual experiments are shown. Scale bar 20 μm.
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ECFPwas excitedwith a 440-nm laser (40 MHz, b80 ps, 1–3 mW) andde-
tected using a HQ 465/30 emission ﬁlter. Time-resolved data from a 3-min
acquisition periodwere analyzedwith PicoQuantMicroTime 200 software,
and ﬂuorescence lifetime was calculated from the TCSPC histogramwith a
tail-ﬁt using a biexponential decay. For acceptor photobleaching FRET ex-
periments prebleach Cy3 and Cy5 images were collected simultaneously
after excitation with the krypton argon laser (561 nm, 1.5% intensity). To
photobleach Cy5, a rectangular region of interest was irradiated for 5 s
with the heliumneon laser (633 nm, 100% intensity). Immediately thereaf-
ter, postbleach Cy3 and Cy5 images were collected with the same settings
as the prebleach images. FRET efﬁciencywas calculated in a Cy3 present re-
gion inside the photobleached region after background correction as
100 × [(Cy3 postbleach − Cy3 prebleach) / Cy3 postbleach]. FLIPglu
measurementswere carried out using aperifusion chamber incorporatedinto an xcellence/Olympus IX81microscope system (Olympus, Hamburg,
Germany) as described [38]. Brieﬂy, ECFP was excited with a
D436/10 ﬁlter (AHF Analysentechnik, Tübingen, Germany). ECFP and
citrine emission were detected simultaneously using a DV-CC Dual
View System (Optical Insights LLC, Tucson, AZ, USA) equipped with a
505 dcxr beam splitter and D465/30 and HQ535/30 emission ﬁlters or
separately with 455DCLP-D480/40 and 530DCLP-D560/40 ﬁlter sets
(AHF Analysentechnik). A ﬂow rate of 1 ml/min Krebs–Ringer solution
was maintained using a peristaltic pump (Ismatec, Zürich, Switzerland).
Images were taken every 2 s with an UPLSAPO 60 × 1.35 numerical aper-
ture oil-immersion objective (Olympus). For analysis of subcellular distri-
bution of ECFP and EYFP fusion constructs D436/10-455DCLP-D480/40
and HC500/24-BS520-HC542/27 ﬁlter sets (AHF Analysentechnik) were
used, respectively. The nuclear to cytoplasmic ﬂuorescence intensity
ratio (N/C-ratio) was calculated from 20 nuclear and 20 cytoplasmic
pixel measurements of each image using xcellence software (Olympus).
Living cells were kept at 60% humidity, 37 °C and 5% CO2 during all
experiments using a Cellcubator (Olympus).
2.6. Statistical analyses
Statistical analyses were performed using the Prism analysis pro-
gram (Graphpad, San Diego, CA, USA).
3. Results
3.1. Interaction and localization of glucokinase andGRP in primary hepatocytes
Using immunostaining and photobleaching FRET we could demon-
strate a direct interaction between endogenous glucokinase and GRP
(Fig. 1). Upon binding of the target proteins, FRET occurred between
Cy3 (glucokinase) and Cy5 (GRP), and photobleaching of Cy5 ﬂuores-
cence in a rectangular region in the nucleus (Fig. 1A) resulted in
enhanced Cy3 ﬂuorescence (Fig. 1B). Interaction between glucokinase
and GRP in the nucleus was ﬁvefold higher at 5 mmol/l glucose than
at 20 mmol/l glucose (Fig. 1C). To study the subcellular localization
of endogenous glucokinase and GRP (Fig. 1D) the N/C-ratio was deter-
mined in dependence on the glucose concentration (Fig. 1D). At 5 mmol/l
glucose glucokinase and GRP showed a comparable N/C-ratio of approxi-
mately 3.5. At 20 mmol/l glucose the N/C-ratio of glucokinase was di-
minished to 2.0, whereas the N/C-ratio of GRP was only reduced to 3.0
(Fig. 1F). Thus, at 20 mmol/l glucose the N/C-ratio of glucokinase was
signiﬁcantly lower than that of GRP (Fig. 1F).
The change in the glucokinase N/C-ratio after administration of glu-
cose was investigated using the ﬂuorescent fusion protein ECFP-GK
(Fig. 2). Notably, the N/C-ratio determined for the overexpressed gluco-
kinase (Fig. 2) was comparable to that of the endogenous glucokinase
(Fig. 1F) and the values were not signiﬁcantly different in rat (Fig. 2A)
and mouse (Fig. 2B, C) hepatocytes. The N/C-ratio of glucokinase was
signiﬁcantly reduced 2 h after addition of 20 mmol/l glucose, but not
after 30 min. In contrast, 0.2 mmol/l fructose or 30 μmol/l of the gluco-
kinase activator CpdA [12] evoked a signiﬁcant reduction in theN/C-ratio
of glucokinase already 30 min after administration (Fig. 2).
3.2. Translocation of glucokinase and GRP in primary rat hepatocytes
To determine the translocation of glucokinase and GRP in primary
hepatocytes, FRAP of overexpressed EYFP-GK, EYFP-GRP, and EYFP (as
control) was measured (Fig. 3). Fluorescence recovery was quantiﬁed
after photobleaching in the nucleus (Fig. 3A). EYFP showed the highest
ﬂuorescence recovery, because of the low molecular mass compared to
the fusion proteins [37], andmoved independent of the glucose concen-
tration between cytoplasm and nucleus (Fig. 3A). Glucokinase, but
not GRP, showed a signiﬁcantly lower ﬂuorescence recovery rate at
20 mmol/l compared to 5 mmol/l glucose. In binuclear hepatocytes the
slope of the ﬂuorescence decrease in one nucleus after photobleaching
Fig. 7. Direct interaction between ECFP-glucokinase and EYFP-GRP in MIN6 cells. MIN6 cells were transiently transfected with ECFP-glucokinase and EYFP-GRP or with the ﬂuorescence
protein EYFP alone as control. (A) Shown is a representative cellwith ECFP-glucokinase in green and EYFP-GRP in red. Scale bar 10 μm. (B) Cellswere incubated for 2 h at 5 mmol/l glucose
and, thereafter, at 5 mmol/l glucose, 20 mmol/l glucose or 5 mmol/l glucose + 30 μmol/l CpdA. The glucokinasenuclear/cytoplasmic ratiowas calculatedbefore, and 30 and120 min after
switching themedium in the same cells. Data are expressed asmeans ± SEM from three individual transfectionswith four cells each. ⁎⁎p b 0.01; ⁎⁎⁎p b 0.001 (ANOVA/Bonferroni's test).
Representative images are shown (C). (D) Fluorescence lifetimewasmeasuredwith an Olympus Fluoview1000 confocal microscope and PicoQuant TimeHarp 200 equipment. Shown are
means ± SEM from four individual experiments. (E) Shown is the lifetime distribution in a representative ECFP-glucokinase and EYFP-GRP expressing cell. ***p b 0.001 compared to
EYFP-transfected cells; ###p b 0.001 compared to cytoplasm (ANOVA/Bonferroni's test).
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(Fig. 3B). Glucokinase, but not GRP showed a signiﬁcantly higher nuclear
export rate at 20 mmol/l compared to 5 mmol/l glucose (Fig. 3C).
To elucidate the dynamics of GRP and glucokinase cellular translo-
cation, primary hepatocytes were transfected with Dendra2 fusion
constructs and incubated at 20 mmol/l glucose. Nuclear irradiation of
Dendra2 fusion constructs with UV light facilitated a spatially limited
irreversible photoconversion of the ﬂuorescence protein. The origin-
ally green emission spectrum switched to a red one as exempliﬁed
for Dendra2-GRP in the right nucleus (R) of a binuclear hepatocyte
(Fig. 4B). Monitoring of the green and red ﬂuorescence intensities
revealed a nuclear import of green Dendra2-GRP and an export of red
Dendra2-GRP in the right nucleus (Fig. 4A). Appearance of red Dendra2-
GRP in the left nucleus (L) clearly indicated GRP shuttling between
the two nuclei (Fig. 4A, B). After 2 h there was a balanced import and
export of GRP in the nucleus, whereas glucokinase exhibited a signiﬁ-
cantly higher nuclear export rate (Fig. 4C).
To calculate the decrease of the red Dendra2 nuclear ﬂuorescence,
experiments with a higher time resolution were conducted (Fig. 5A,
B). As expected from the lowmolecularmass of 28 kDa [37], the nuclear
export rates of the photoconverted red Dendra2were higher than those
of the Dendra2-GK and Dendra2-GRP fusion proteins and independent
from the glucose concentration (Fig. 5B). The translocation of Dendra2-
GRP showed comparable nuclear export rates from the nucleus at 5 and
20 mmol/l glucose (Fig. 5B). In contrast, the nuclear export of Dendra-
GKwas nearly tenfold higher at 20 mmol/l glucose than at 5 mmol/l glu-
cose (Fig. 5A, B). Thus, high glucose concentrations primarily increased
the nuclear export of glucokinase but not of GRP or a glucokinase:GRP
complex from the nucleus to the cytoplasm (Fig. 5C).3.3. Impact of theGRP on compartment speciﬁc glucokinase enzyme activity
and immunoreactivity in MIN6 cells in comparison to primary hepatocytes
In the next step we investigated if glucokinase translocation to the
nucleus could be detected in insulin-secretingMIN6 cells after transfection
withGRP. Primary rat hepatocytes andMIN6 cellswere cultured for 24 h in
medium with 10 mmol/l glucose. Glucokinase immunoreactivity and en-
zyme activity were detectable in the nucleus of rat hepatocytes (Fig. 6A,
B). MIN6 cells, which do not endogenously express GRP, were transiently
transfected with EYFP-GRP (Fig. 6D) or as a control with the ﬂuorescence
protein EYFP (Fig. 6C). Like endogenous GRP in hepatocytes (Fig. 1),
EYFP-GRP was predominantly detected inside the nucleus with a smaller
fraction residing in the cytosol (Fig. 6D). In EYFP-GRP expressing MIN6
cells glucokinase immunoreactivity was detectable inside the nucleus. Glu-
cokinase enzyme activity was signiﬁcantly decreased in the extranuclear
fraction but markedly increased in the nuclear fraction compared to EYFP
control cells (Fig. 6A, B).
The N/C-ratio of ECFP-glucokinase in the presence of EYFP-GRP
(Fig. 7A–C)was 2.0 at 5 mmol/l glucose and thus, lower than in primary
hepatocytes (Fig. 2). However, glucose-induced changes of the glucoki-
nase N/C-ratio were comparable to those in hepatocytes (Fig. 2).
Addition of 20 mmol/l glucose signiﬁcantly reduced the glucokinase
N/C-ratio after 2 h, whereas addition of 30 μmol/l of the glucokinase
activator CpdA provoked a decrease already after 30 min (Fig. 7B, C).
To demonstrate a direct interaction between glucokinase and GRP in
MIN6 cells with a high spatial resolution, lifetime FRET measurements
were performed in cells overexpressing ECFP-glucokinase and EYFP-
GRP or EYFP (as control). Time-correlated single photon count
(TCSPC) histograms were analyzed for calculation of the average lifetime
(Fig. 7D) and the corresponding single lifetimes. The lifetime was signiﬁ-
cantly decreased in MIN6 cells overexpressing ECFP-glucokinase and
EYFP-GRP in comparison to EYFP suggesting a direct interaction between
glucokinase and GRP (Fig. 7D). Consistent with the localization of the GRP
(Fig. 7A) a more signiﬁcant interaction was observed in the nucleus
(Fig. 7D, E).3.4. Real-time analysis of the glucose concentration in the nucleus and
cytoplasm of primary rat hepatocytes, insulin-secreting cell lines and
non-endocrine COS cells
Since glucose plays a pivotal role for the dissociation of the glucoki-
nase:GRP complex in the nucleus we were interested in how nuclear
glucose concentrations adapt to changes of extracellular glucose con-
centrations. Real-time glucose ﬂux measurements were performed
using the FLIPglu sensor [38], which is based on the intramolecular
FRET response of an ECFP/citrine pair fused to a glucose-speciﬁc bacte-
rial periplasmic binding protein (Fig. 8A, B). Generation of a nuclear
targeted version of FLII12Pglu-700μ-δ6 (FLIPglu-NUC) enabled monitor-
ing of glucose dynamics in the nucleus (Fig. 8A, C). Finally, the glucose
inﬂux rate (Fig. 8D) and the glucose efﬂux/metabolism rate (Fig. 8E)
were quantiﬁed from the time-dependent plots of cytoplasmic or nucle-
ar glucose concentrations (Fig. 8F) [38].
In hepatocytes the switch from 0 to 10 mmol/l glucose in the
perifusion medium resulted in a rapid increase of glucose both in the
cytoplasmic and nuclear compartment (Fig. 8F). In the cytoplasm com-
parable glucose inﬂux rates were measured in MIN6 cells and hepato-
cytes. However, glucose inﬂux in the nucleus was twofold higher in
hepatocytes than in MIN6 and also INS1E cells (Fig. 8D). The nuclear
glucose uptake rate in INS1E cells was comparable to that in MIN6
cells. Expression of GRP did not change the nuclear glucose inﬂux in
MIN6 cells (Fig. 8D). The MIN6 and INS1E insulin-secreting cell lines
showed signiﬁcantly higher nuclear glucose uptake kinetics than non-
endocrine COS cells. The rapid equilibrium of nuclear glucose con-
centration in hepatocytes raised the question whether this import is
conferred by a facilitative glucose transporter, most probably by
GLUT2, which is physiologically expressed in hepatocytes and rodent
beta cells. Overexpression of GLUT2 in insulin-secreting RINm5F cells,
not endogenously endowed with GLUT2 [40], signiﬁcantly increased
both the cytoplasmic and nuclear glucose inﬂux (Fig. 8G). However,
the resulting nuclear glucose inﬂux rate (Fig. 8G) was comparable to
that of MIN6 and INS1E cells, endogenously endowed with GLUT2 [38]
but signiﬁcantly lower when compared to hepatocytes (Fig. 8D).
After removing glucose from the perifusion medium hepatocytes
showed a slightly lower cytoplasmic glucose efﬂux and metabolic rate
in the cytoplasm than MIN6 and INS1E cells (Fig. 8E). However, the
cytoplasmic glucose efﬂux/metabolism rate in hepatocytes was 3-fold
higher than in COS cells which do not express glucokinase (Fig. 8E).
The nuclear glucose efﬂux and metabolic rates of MIN6 and INS1E
cells were comparable to those observed in COS cells, whereas hepato-
cytes showed a twofold higher rate (Fig. 8E). Importantly, expression of
GRP inMIN6 cells and, thus, nuclear localization of glucokinase at a level
comparable to hepatocytes (Fig. 5B) signiﬁcantly increased the nuclear
efﬂux/metabolism rate (Fig. 8E).4. Discussion
It was the aim of this study to compare the dynamics of glucokinase
andGRP shuttling in primary hepatocytes in dependence on the glucose
concentration. Glucose is the key modulator of the glucokinase confor-
mation thereby affecting the binding afﬁnity to GRP. In the absence of
glucose, glucokinase relaxes to a super-opened conformation [10,14,16],
which allows interaction with the liver speciﬁc GRP [1,8,10,14–16]. In
addition to the competitive inhibition [9] GRP sequesters glucokinase to
the nucleus [1,8,19,26,28,29,32–36]. Knocking downGRP inmice resulted
in cytoplasmic localization of glucokinase in the liver [42]. In beta cells,
where GRP is not expressed, glucokinase is mainly localized in the
extranuclear compartments with the highest activity in the cytoplasm
[1]. In agreement with previous experiments [11,33,35,36,43], we
could show that overexpression of GRP in MIN6 cells evokes a translo-
cation of glucokinase to the nucleus. In the present study we could
now demonstrate a direct interaction of glucokinase and GRP in the
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implicate that the nuclear import of glucokinase essentially requires
GRP.
While there is general consent about the import mechanism of
glucokinase into the nucleus as a glucokinase:GRP complex the mecha-
nisms and dynamics of nuclear glucokinase export are not fully clariﬁed
with respect to the role of GRP, which also undergoes cycling between
nucleus and cytoplasm [1,8,19,26,28,29,32–36]. In line with previous
experiments [11,24,27,28,34,44]we could show that in rodent hepatocytes
the N/C-ratio of glucokinase was signiﬁcantly reduced at 20 mmol/l
compared to 5 mmol/l glucose. The N/C-ratio of GRP was also inﬂu-
enced by high glucose, but signiﬁcantly less than the N/C ratio of gluco-
kinase. However, the N/C-ratio does not provide information about
complex formation between glucokinase and GRP. We therefore in-
vestigated the direct interaction of endogenous proteins by acceptor
photobleaching FRET in primary rat hepatocytes. In the nucleus, interac-
tion between glucokinase and GRP was signiﬁcant at 5 mmol/l glucose,
but reduced at 20 mmol/l glucose. Thus, the glucose-dependent dissoci-
ation of the glucokinase:GRP complex in the nucleus appears to be the
prerequisite for a GRP-independent nuclear export of glucokinase.
To resolve the kinetics of the glucokinase nuclear export we tracked
the distribution of ECFP-glucokinase in single primary hepatocytes cul-
tured at 5 mmol/l glucose after adding 20 mmol/l glucose, 0.2 mmol/l
fructose or 30 μmol/l glucokinase activator CpdA. In agreement with
previous studies [12,27,34] we observed a signiﬁcant nuclear export of
glucokinase in response to fructose and CpdA within 30 min, but for
glucose after 2 h. Identical results were observed in MIN6 cells for
glucose and CpdA after overexpression of GRP. It should be noted that
fructose cannot be applied to MIN6 cells to induce a strong increase of
fructose-1-phosphate, because of the low activity of fructokinase in
pancreatic beta cells compared to hepatocytes [45]. Glucose induces
a much lower increase of fructose-1-phosphate in comparison to a
fructose supply [20]. Binding of fructose-1-phosphate to GRP induces a
conformational shift to render the protein inaccessible for interaction
with glucokinase [21,22]. The glucokinase activator CpdA retains gluco-
kinase in a closed conformation in which the protein cannot interact
with GRP [12]. Thus, fructose and CpdA evoked a dissociation of the
glucokinase:GRP complex already at a low glucose concentration of
5 mmol/l. This results in an increase of free glucokinase in the nucleus,
which is accessible to the export machinery explaining the fast glucoki-
nase nuclear export kinetics. However, after a standard meal with
complex carbohydrates glucose increases predominantly in hepatocytes
inducing slower dynamics of the glucokinase nuclear export due to its
effects on glucokinase conformation.
To further test this hypothesis in hepatocytes, we performed direct
kinetic analyses of the glucokinase and GRP nuclear export after 2 h in-
cubationat5 and20 mmol/l glucosebymeansof selectivephotoconversion
with Dendra2 fusion proteins and FRAP experimentswith EYFP fusion pro-
teins. By photoconversion of Dendra2 a stable red ﬂuorescence protein
fraction is produced, which can be followed up in living cells for hours
[41,46,47]. Selecting hepatocytes with two nuclei protein movement
of GRP could be monitored simultaneously on the import and export
level. Our data indicate that apart from a portion of GRP, which residedFig. 8. Nuclear and cytoplasmic glucose inﬂux and efﬂux in rat hepatocytes compared to INS1
measured by cellular expression of the FLIPglu glucose nanosensor (A)without (B) orwith a nuc
real-time ﬂuorescence microscopy COS cells, INS1E cells, MIN6 cells, and primary rat hepat
(20–40 min), and ﬁnally without glucose as exemplarily shown for hepatocytes (F) transfect
FRET ratio was calculated from citrineem/ECFPem at ECFPex. COS cells, INS1E cells, MIN6 cells, an
localized FLIPglu-Nuc (black bars). In addition, MIN6 cells were co-transfected with pTagRFP-G
(D) was quantiﬁed by calculating the ratio increase upon glucose stimulation. Glucose metabo
deprivation. Data are expressed as means ± SEM from three to four individual transfections w
expressing FLIPglu-Nuc (ANOVA/Bonferroni's test). (E) ⁎p b 0.05 compared to COS cells, INS1
compared to MIN6 cells expressing FLIPglu-Nuc (Student's t test). (G) FLIPglu (white bars) o
cells and rat GLUT2 overexpressing RINm5F cells (striped bars) and glucose inﬂux was calcul
experiments in total. ⁎p b 0.05; ⁎⁎⁎p b 0.001 (ANOVA/Bonferroni's test).in the nucleus, another portion moved independent of the glucose
concentration between nucleus and cytoplasm. The experiments clearly
show that glucokinase and GRP exhibit different nuclear export kinetics
in hepatocytes. Glucokinase, but not GRP showed changes in theﬂuores-
cence recovery rate as a function of the glucose concentration. This sug-
gests that the dynamics of the glucokinase:GRP complex formation and
dissociation is the primary driving force of the glucokinase nuclear ex-
port. The nuclear abundance of glucokinase:GRP complex is determined
by the GRP concentration, which is high in the nucleus of hepatocytes
both at 20 mmol/l glucose and at 5 mmol/l glucose. Thus, the timely nu-
clear equilibration of glucose in response to changes of extracellular glu-
cose concentrations is important for dissociation of the glucokinase:GRP
complex. From our data we cannot entirely exclude some nuclear export
of the glucokinase:GRP complex. However, the kinetic analyses using
glucokinase and GRP ﬂuorescence fusion proteins strongly suggest the
former described mechanism to play the major role in hepatocytes.
The structure of the nuclear pore should, at least theoretically, allow
a rapid equilibration by diffusion as postulated for small molecules
[37,48]. Using the FLII12Pglu-700μ-δ6 glucose sensor construct [38,39,49]
we found more rapid equilibration kinetics in hepatocytes than in insulin-
secreting cells and COS cells. In hepatocytes as well as rodent beta
cells glucose uptake from the extracellular space is mediated by the
GLUT2 glucose transporter [50–52]. This can explain the higher cyto-
plasmic glucose inﬂux and because of the faster intracellular equilibra-
tion also the higher nuclear glucose inﬂux in MIN6 and INS1E cells and
hepatocytes compared to COS cells. However, hepatocytes showed a
signiﬁcantly higher nuclear glucose inﬂux than MIN6 and INS1E cells,
whereas the cytoplasmic glucose inﬂux was comparable. The observed
kinetics for cytoplasmic and nuclear glucose inﬂux were comparable in
hepatocytes suggesting a unique nuclear glucose inﬂux capacity in the
liver compared to other tissues. The presence of the GRP cannot explain
the higher nuclear glucose inﬂux in hepatocytes, because overexpres-
sion of the GRP did not increase the nuclear glucose inﬂux inMIN6 cells.
The FLII12Pglu-700μ-δ6 based real-time method [38,39,49] pro-
vided further insights into the dynamics of nuclear glucose handling.
After stopping the external supply, the nuclear glucose efﬂux and
metabolism rate was signiﬁcantly higher in hepatocytes than in
MIN6, INS1E, and COS cells. However, overexpression of GRP in
MIN6 cells resulted in a more rapid decrease of nuclear glucose.
These observations can be explained by sequestration of glucokinase
to the nucleus by GRP and subsequent release from the glucokinase:
GRP complex after increasing the nuclear glucose concentration.
Nuclear glucose could then be metabolized by free glucokinase
enzyme. This hypothesis is supported by the observation that gluco-
kinase enzyme activity could be measured in the nuclear fraction of
GRP overexpressing MIN6 cells, but not in control MIN6 cells. In
line with these ﬁndings, we observed decreased glucose elimination
in hepatocytes, which can be accounted for by the fact that a frac-
tion of active glucokinase resides in the nucleus whereas in insulin-
secreting cells all active glucokinase is present in the cytosol.
In conclusion, we demonstrated that the increase in the nuclear
glucose concentration releases glucokinase from the complex with
the GRP and most likely mediates a GRP independent glucokinaseE and MIN6 cells and COS cells. Nuclear and cytoplasmic glucose inﬂux and efﬂux were
lear localisation sequence (C) as exemplarily shown inMIN6 cells. Scale bar 10 μm.During
ocytes were perifused without glucose (0–20 min), thereafter with 10 mmol/l glucose
ed with FLIPglu (gray line) or the nuclear localized FLIPglu-Nuc (black line). Finally, the
d primary rat hepatocytes were transfectedwith either FLIPglu (white bars) or the nuclear
RP and FLIPglu-Cyt (white striped bars) or FLIPglu-Nuc (black striped bars). Glucose inﬂux
lism/efﬂux (E) was quantiﬁed by calculating the subsequent ratio decrease after glucose
ith 7–20 experiments in total. (D) ⁎⁎⁎p b 0.001 compared to both, INS1E and MIN6 cells
E cells, and MIN6 cells expressing FLIPglu-Nuc (ANOVA/Bonferroni's test); ###p b 0.001
r FLIPglu-Nuc (black bars) real-time ﬂuorescence microscopy was performed in RINm5F
ated. Data are expressed as means ± SEM from three individual transfections with 9–22
563M.T. Kaminski et al. / Biochimica et Biophysica Acta 1843 (2014) 554–564export. Furthermore we provide evidence that a rapid cytoplasmic to
nuclear glucose ﬂux is typical for hepatocytes. Our data emphasize
the differential dynamics of glucokinase shuttling mechanisms inhepatocytes that may be crucially determined by the equilibration
kinetics of glucose and its subsequent effects on glucokinase con-
formation and eventually on glucokinase:GRP complex formation.
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